Hardik Jigishkumar Desai, promoter and director of Trident Lifeline Limited, has acquired additional equity shares in the company through an off-market transaction, increasing his overall shareholding percentage. The acquisition was disclosed in compliance with SEBI regulations governing substantial share acquisitions.

Transaction Details

The off-market acquisition involved 55,800 equity shares, representing 0.47% of the company's total share capital and 0.45% of the diluted share capital. The transaction was completed on March 24, 2026, as per the regulatory filing submitted to BSE Limited.

Shareholding Changes

Following the acquisition, Desai's total shareholding in Trident Lifeline Limited has increased substantially. His holding has grown from 27,02,150 shares to 27,57,950 shares, marking a significant increase in his stake in the company.

Company Capital Structure

Trident Lifeline Limited's equity share capital structure remained unchanged following this transaction. The company maintains its current capital base with no alterations to the total number of outstanding shares.

Current Capital Structure:

• Equity Share Capital: ₹11,93,30,000
• Total Equity Shares: 1,19,33,000 shares
• Face Value per Share: ₹10
• Total Diluted Share Capital: ₹12,49,34,000 (1,24,93,400 shares)

Regulatory Compliance

The disclosure was made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. As a promoter and director of the company, Desai is required to disclose any changes in his shareholding that cross specified thresholds. The filing was submitted to BSE Limited, where Trident Lifeline Limited's shares are listed, ensuring full regulatory compliance and transparency for market participants.

Trident Lifeline Limited has announced the acquisition of an additional 2.67% equity stake in its subsidiary Trident Mediquip Limited, increasing its shareholding from 57.10% to 59.77%. The company disclosed this information to BSE Limited on March 18, 2026, under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Acquisition Details

The acquisition involved purchasing additional equity shares from existing shareholders of Trident Mediquip Limited. Prior to this transaction, Trident Lifeline's shareholding in the subsidiary had decreased to 57.10% following a private placement of equity shares to other shareholders by Trident Mediquip Limited.

About Trident Mediquip Limited

Trident Mediquip Limited is a subsidiary company incorporated under the provisions of the Companies Act, 2013, with its registered office in Surat, Gujarat. The company operates in the pharmaceuticals industry and was incorporated on October 19, 2019.

Historical Performance

The subsidiary's turnover performance over the last three financial years shows:

Related Party Transaction

The acquisition qualifies as a related party transaction since Trident Mediquip Limited is a subsidiary of Trident Lifeline Limited. Several promoters and promoter group members, including directors and their relatives, have interests in both entities. The company has confirmed that the transaction is being undertaken on an arm's length basis.

Regulatory Compliance

The disclosure was made in compliance with SEBI (LODR) Regulations, 2015 and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The company secretary and compliance officer Nikita Sharma signed the regulatory filing on March 18, 2026.